Sarepta Therapeutics (SRPT) FCF Margin Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,600.00 |
| Dec 31, 2025 | 93,192.00 |
| Sep 30, 2025 | 116,193.00 |
| Jun 30, 2025 | 52,479.00 |
| Mar 31, 2025 | -514,800.00 |
| Dec 31, 2024 | 18,904.00 |
| Sep 30, 2024 | 5,449.00 |
| Jun 30, 2024 | 9,716.00 |
| Mar 31, 2024 | 12,036.00 |
| Dec 31, 2023 | 15,306.00 |
| Sep 30, 2023 | 12,647.00 |
| Jun 30, 2023 | -45,856.00 |
| Mar 31, 2023 | -1,230.00 |
| Dec 31, 2022 | 171.00 |
| Sep 30, 2022 | 9,244.00 |
| Jun 30, 2022 | 21,547.00 |
| Mar 31, 2022 | -10,346.00 |
| Dec 31, 2019 | 10.57 Mn |
| Sep 30, 2019 | 443,467.00 |
| Jun 30, 2019 | 160,311.00 |
| Mar 31, 2019 | 36,500.00 |
| Dec 31, 2018 | 53,287.00 |
| Sep 30, 2018 | 33,878.00 |
| Jun 30, 2018 | 24,985.00 |
| Mar 31, 2018 | 26,127.00 |
| Dec 31, 2017 | 3,654.00 |
| Sep 30, 2017 | -2,508.00 |
| Jun 30, 2017 | -19,950.00 |
| Mar 31, 2017 | -30,076.00 |